Enzymatica publ AB (ENZY) — Strategic Asset Allocation Index
Enzymatica publ AB (ENZY) has a Strategic Asset Allocation Index of 8.6% as of September 2025. Strategic assets (PP&E of Skr11.70 Million plus long-term investments of Skr-) total Skr11.70 Million, measured against net assets of Skr135.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Enzymatica publ AB Strategic Asset Allocation Index (2007–2024)
This chart shows how Enzymatica publ AB's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2024. As of September 2025, the index stands at 8.6%, representing strategic assets of Skr11.70 Million against net assets of Skr135.68 Million SEK. Explore Enzymatica publ AB (ENZY) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Enzymatica publ AB (2007–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Enzymatica publ AB from 2007 to 2024, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Enzymatica publ AB.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 8.2% | Skr14.40 Million | Skr14.40 Million | Skr- | Skr176.37 Million | ▼ -13.4 pp |
| 2023 | 21.5% | Skr16.48 Million | Skr16.48 Million | Skr- | Skr76.61 Million | ▲ +8.5 pp |
| 2022 | 13.0% | Skr16.40 Million | Skr16.40 Million | Skr- | Skr126.29 Million | ▲ +0.9 pp |
| 2021 | 12.1% | Skr15.16 Million | Skr15.16 Million | Skr- | Skr124.97 Million | ▲ +2.5 pp |
| 2020 | 9.6% | Skr10.26 Million | Skr10.26 Million | Skr- | Skr106.65 Million | ▲ +2.1 pp |
| 2019 | 7.5% | Skr8.95 Million | Skr6.78 Million | Skr2.17 Million | Skr119.20 Million | ▲ +3.9 pp |
| 2018 | 3.6% | Skr5.77 Million | Skr4.54 Million | Skr1.24 Million | Skr159.66 Million | ▼ -0.8 pp |
| 2017 | 4.4% | Skr4.89 Million | Skr4.87 Million | Skr23.00K | Skr110.70 Million | ▲ +1.3 pp |
| 2016 | 3.1% | Skr4.40 Million | Skr4.38 Million | Skr23.00K | Skr142.04 Million | ▲ +1.8 pp |
| 2015 | 1.3% | Skr276.00K | Skr276.00K | Skr- | Skr21.98 Million | ▲ +0.8 pp |
| 2014 | 0.5% | Skr303.00K | Skr303.00K | Skr- | Skr62.42 Million | ▼ -0.9 pp |
| 2013 | 1.4% | Skr220.00K | Skr220.00K | Skr- | Skr15.73 Million | ▲ +1.3 pp |
| 2012 | 0.1% | Skr17.00K | Skr17.00K | Skr- | Skr14.06 Million | ▼ -0.6 pp |
| 2011 | 0.8% | Skr25.00K | Skr25.00K | Skr- | Skr3.31 Million | ▲ +0.4 pp |
| 2010 | 0.3% | Skr15.00K | Skr15.00K | Skr- | Skr4.40 Million | ▼ -20.8 pp |
| 2007 | 21.2% | Skr11.00K | Skr11.00K | Skr- | Skr52.00K | — |